Skip to content

Effects of digital cognitive-behavioral psychotherapy for insomnia (dCBT-I) KVT-I on depression

Effects of digital cognitive-behavioral psychotherapy for insomnia (dCBT-I) KVT-I on depression - INSTEAD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030919
Enrollment
122
Registered
2023-01-09
Start date
2023-01-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.0 F33.0 F32.1 F33.1 F32.2 F33.2 F32.8 F33.8 F32.9 F33.9

Interventions

Group 1: Group 1 receives access to somnio (mementor DE GmbH), a digital health application that delivers cognitive-behavioral psychotherapy for insomnia (24 weeks). Group 2: Group 2 waits for 24 week

Sponsors

Heinrich-Heine-Universität Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Current depression (diagnostic interview & Beck Depression Inventory [BDI] > 8). - Self-reported sleep difficulties (diagnostic interview & ISI > 10) - Confident use of the smartphone/tablet/computer - Stable Internet access

Exclusion criteria

Exclusion criteria: - Bipolar disorder - Epilepsy - Pregnancy - Presence of another sleep disorder (diagnostic interview) - Regular drug and alcohol use (> 3 glasses of alcohol per day, more than 21 days), marijuana use (> 1x per week; self-report) - Acute suicidality (suicide item > 1 in the Beck Depression Inventory BDI & suicidality according to questioning in a telephone interview) - Psychosis

Design outcomes

Primary

MeasureTime frame
Depression severity, post-treatment (12 weeks post-randomization) as measured with the Patient Health Questionnaire (PHQ-9).

Secondary

MeasureTime frame
- Insomnia severity (ISI; 12 & 24 weeks post-randomization) - Daytime sleepiness (ESS; 12 & 24 weeks post-randomization) - Fatigue (FSS; 12 & 24 weeks post-randomization) - Quality of life (WHQOL_BREF; 12 & 24 weeks post-randomization) - Emotional state (PANAS; 12 & 24 weeks post-randomization) - Sleep continuity (sleep diary; 12 weeks post-randomization) - Self-efficacy (PCS; 12 & 24 weeks post-randomization) - Emotion regulation (RSQ; 12 & 24 weeks post-randomization)

Countries

Germany

Contacts

Public ContactAnnika Gieselmann

Heinrich-Heine-Universität Düsseldorf

Annika.Gieselmann@hhu.de+49 211 18-10584

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026